It was not the promise of a patent that produced COVID-19 vaccines astonishingly fast in the first place, says the Financial Times’ Tim Harford.
from Latest News https://ift.tt/3fEvGI3
Commentary: Vaccine patent row shows need to rethink intellectual property
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment